본문 바로가기
KERD
논문KCI 등재

약물 알레르기 꼬리표 떼기

Drug Allergy Delabeling

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Drug allergy labels are critical for ensuring patient safety; however, unverified labels established without a rigorous diagnostic process can lead to suboptimal medication use, treatment failures, increased adverse drug reactions, and higher healthcare costs. In particular, unconfirmed penicillin allergy labels are strongly linked to the inappropriate use of broadspectrum antibiotics, contributing to the rise of multidrug-resistant infections. The process of drug allergy delabeling enables many patients to safely use the medication in question, thereby facilitating the appropriate use of antibiotics and reducing unnecessary avoidance. Such delabeling is particularly vital as part of antimicrobial stewardship programs, as it enhances patient outcomes while decreasing healthcare expenses. Moving forward, the development of standardized procedures, enhanced awareness among patients and healthcare providers, and the implementation of validated risk-stratification methods is essential for more accurate and efficient drug allergy delabeling. These advancements will help mitigate the adverse effects of inaccurate labels and support optimal patient care.

Abstract

Drug allergy labels are critical for ensuring patient safety; however, unverified labels established without a rigorous diagnostic process can lead to suboptimal medication use, treatment failures, increased adverse drug reactions, and higher healthcare costs. In particular, unconfirmed penicillin allergy labels are strongly linked to the inappropriate use of broadspectrum antibiotics, contributing to the rise of multidrug-resistant infections. The process of drug allergy delabeling enables many patients to safely use the medication in question, thereby facilitating the appropriate use of antibiotics and reducing unnecessary avoidance. Such delabeling is particularly vital as part of antimicrobial stewardship programs, as it enhances patient outcomes while decreasing healthcare expenses. Moving forward, the development of standardized procedures, enhanced awareness among patients and healthcare providers, and the implementation of validated risk-stratification methods is essential for more accurate and efficient drug allergy delabeling. These advancements will help mitigate the adverse effects of inaccurate labels and support optimal patient care.

참고문헌 (26)

  1. Edwards IR, "Adverse drug reactions : definitions, diagnosis, and management", Lancet, 356, pp.1255~1259 (2000)
  2. Formica D, "The economic burden of preventable adverse drug reactions : a systematic review of observational studies", Expert Opin Drug Saf, 17, pp.681~695 (2018)
  3. Wilkerson RG, "Drug hypersensitivity reactions", Immunol Allergy Clin North Am, 43, pp.473~489 (2023)
  4. Stone CA Jr, "The challenge of de-labeling penicillin allergy", Allergy, 75, pp.273~288 (2020)
  5. Norton AE, "Antibiotic allergy in pediatrics", Pediatrics, 141, pp.e20172497~ (2018)
  6. Vyles D, "Parent-reported penicillin allergy symptoms in the pediatric emergency department", Acad Pediatr, 17, pp.251~255 (2017)
  7. Ibia EO, "Antibiotic rashes in children : a survey in a private practice setting", Arch Dermatol, 136, pp.849~854 (2000)
  8. Macy E, "Are cephalosporins safe for use in penicillin allergy without prior allergy evaluation?", J Allergy Clin Immunol Pract, 6, pp.82~89 (2018)
  9. Blumenthal KG, "Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy : population based matched cohort study", BMJ, 361, pp.k2400~ (2018)
  10. Blumenthal KG, "The impact of a reported penicillin allergy on surgical site infection risk", Clin Infect Dis, 66, pp.329~336 (2018)
  11. MacFadden DR, "Impact of reported beta-lactam allergy on inpatient outcomes : a multicenter prospective cohort study", Clin Infect Dis, 63, pp.904~910 (2016)
  12. Briody VA, "Use of cefazolin for group B Streptococci prophylaxis in women reporting a penicillin allergy without anaphylaxis", Obstet Gynecol, 127, pp.577~583 (2016)
  13. Trubiano JA, "Antimicrobial allergy ‘labels’ drive inappropriate antimicrobial prescribing : lessons for stewardship", J Antimicrob Chemother, 71, pp.1715~1722 (2016)
  14. Li M, "A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of ‘penicillin allergy’ in a UK teaching hospital", J Clin Pathol, 67, pp.1088~1092 (2014)
  15. Picard M, "Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital", J Allergy Clin Immunol Pract, 1, pp.252~257 (2013)
  16. Wu JH, "Potential negative effects of antimicrobial allergy labelling on patient care : a systematic review", Can J Hosp Pharm, 71, pp.29~35 (2018)
  17. Blumenthal KG, "The cost of penicillin allergy evaluation", J Allergy Clin Immunol Pract, 6, pp.1019~1027 (2018)
  18. Vyles D, "Antibiotic use after removal of penicillin allergy label", Pediatrics, 141, pp.e20173466~ (2018)
  19. Sacco KA, "Clinical outcomes following inpatient penicillin allergy testing : a systematic review and meta-analysis", Allergy, 72, pp.1288~1296 (2017)
  20. Trubiano J, "Antimicrobial stewardship’s new weapon? A review of antibiotic allergy and pathways to ‘delabeling’", Curr Opin Infect Dis, 26, pp.526~537 (2013)
  21. Trubiano JA, "Penicillin allergy is not necessarily forever", JAMA, 318, pp.82~83 (2017)
  22. Huang KG, "The impact of reported beta-lactam allergy in hospitalized patients with hematologic malignancies requiring antibiotics", Clin Infect Dis, 67, pp.27~33 (2018)
  23. Devchand M, "Pathways to improved antibiotic allergy and antimicrobial stewardship practice : the validation of a beta-lactam antibiotic allergy assessment tool", J Allergy Clin Immunol Pract, 7, pp.1063~1065 (2019)
  24. Staicu ML, "Implementation of a penicillin allergy screening tool to optimize aztreonam use", Am J Health Syst Pharm, 73, pp.298~306 (2016)
  25. Confino-Cohen R, "Oral challenge without skin testing safely excludes clinically significant delayed-onset penicillin hypersensitivity", J Allergy Clin Immunol Pract, 5, pp.669~675 (2017)
  26. Tucker MH, "Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of Marine recruits", J Allergy Clin Immunol Pract, 5, pp.813~815 (2017)

관련 논문AI추천

항생제 약물알레르기의 진단과 관리김주희대한내과학회 · 대한내과학회지2021 · 제96권 제4호약물과민반응 환자에서 탈감작요법 적용강혜련, 윤정은, 정지웅대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2023 · 제11권 제2호사용 전 베타락탐 항생제 피부시험의 유용성에 대한 전문가 의견강혜련, 김성렬, 김세훈, 김수정, 박종숙, 박혜정, 서동인, 심다운, 양민석, 이재현, 이화영, 정재우, 최미라대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2022 · 제10권 제1호약물알레르기 검사의 시행과 해석: 전문가 의견서강혜련, 권재우, 권혁수, 김민혜, 김세훈, 김태범, 박해심, 반가영, 서동인, 송우정, 신유섭, 양민석, 이병재, 이애영, 이정민, 임경환, 정재우, 조상헌, 대한천식알레르기학회 표준화위원회대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2017 · 제5권 제5호약물알레르기검사의 실태에 관한 설문조사강혜련, 고영일, 김세훈, 김정은, 김주희, 김태범, 박중원, 박창한, 손성욱, 예영민, 오미정, 이상록, 이소희, 정재우, 조영주대한천식알레르기학회 · 천식 및 알레르기2011 · 제31권 제4호Current practice for diagnosing immediate drug hypersensitivity reactions in KoreaMin-Suk Yang, Sang-Heon Cho, Sung-Yoon Kang, Woo-Jung Song대한내과학회 · The Korean Journal of Internal Medicine2021 · 제36권 제1호

이 간행물의 다른 논문 (9건)